Sun Pharma receives US FDA nod for hyperactivity drug - Economic Times
Moneycontrol.
Sun Pharma: Gets FDA approval for new drug - Healthcare Digital (press release)
Biomed Middle EastSun Pharma: Gets FDA approval for new drugHealthcare Digital (press release)It further added that the company has received 180 days marketing exceptionality for these atomoxetine hydrochloride capsules.
Lilly wins generic Strattera delay - Indianapolis Star
: RBNL to raise Rs 400 cr via preferential issue - Financial Express
: RBNL to raise Rs 400 cr via preferential issueFinancial ExpressThe company's subsidiary has received abbreviated new drug application approval from the US Food & Drug Administration to market generic atomoxetine .
Judge agrees to temporary ban on Strattera generics - Pharma Times
Judge agrees to temporary ban on Strattera genericsPharma TimesThe company has reportedly won a two-week breather from the launch of generic versions of Strattera (atomoxetine) to allow it to seek further injunctions .